Historical record - last NADAC publication: 8/23/2023
Product Information
LETROZOLE 2.5 MG TABLET is a generic product labeled by Yiling Pharmaceutical Inc., priced at $0.1203 per EA under NDC 69117000401. Its NADAC has been published 185 times since Feb 12, 2020.
Strength
2.5 mg/1
Manufacturer
Yiling Pharmaceutical Inc.NDC
69117000401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
8/23/2023
Active Ingredients
LETROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205869On Market Since
9/5/2019
Pharmacological Classes
Price Statistics
The NADAC for LETROZOLE 2.5 MG TABLET has been published 185 times since Feb 12, 2020, and over the history we have for it it has declined 12.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1203 per EA |
|---|---|
| All-time high | $0.1485 (Sep 16, 2020) |
| All-time low | $0.1009 (Jun 21, 2023) |
| Median price | $0.1406 |
| Average price | $0.1336 |
| Largest weekly change | +28.5% (Jan 18, 2023) |
| Weeks tracked | 185 |
| Tracking since | Feb 12, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LETROZOLE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by Yiling Pharmaceutical Inc., is $0.1203 per EA (NDC 69117000401), effective Aug 23, 2023.
How has the price of LETROZOLE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has declined 12.7%. It has been tracked across 185 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?
Since Feb 12, 2020, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1009 (Jun 21, 2023) to a high of $0.1485 (Sep 16, 2020), with a median of $0.1406 per EA.
Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LETROZOLE 2.5 MG TABLET, but none are currently priced below it.
Who manufactures LETROZOLE 2.5 MG TABLET?
LETROZOLE 2.5 MG TABLET (NDC 69117000401) is labeled by Yiling Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification